Table 1 Demographics and clinical characteristics of pSLE patients (N = 146)
Features | CMV positive group (N = 109) | CMV negative group (N = 37) | OR (95%CI) | P value |
|---|---|---|---|---|
Demographic Data | ||||
 Age of diagnosis (mean±SD) | 11.81±2.07 | 12.33±1.91 | -0.52a (-1.29;0.24) | 0.18 |
 Female (%) | 87(79.8) | 28(75.7) | 1.27 (0.53;3.08) | 0.595 |
 New-onset (%) | 46(42.2) | 9(24.3) | 2.27 (0.98;5.27) | 0.052 |
Clinical manifestations | ||||
 Fever (%) | 47(43.1) | 7(18.9) | 3.25 (1.31;8.04) | 0.008 |
 Mucocutaneous (%) | 71(65.1) | 20(54.1) | 1.59 (0.75;3.39) | 0.229 |
 Musculoskeletal (%) | 47(43.1) | 7(18.9) | 3.25 (1.31;8.04) | 0.008 |
 Renal (%) | 69(63.3) | 21(56.8) | 1.31 (0.62;2.81) | 0.479 |
 Pleuropulmonary (%) | 58(53.2) | 16(43.2) | 1.49 (0.7;3.16) | 0.295 |
 Gastrointestinal (%) | 13(11.9) | 1(2.7) | 4.88 (0.62;38.62) | 0.118 |
 Neuropsychiatric (%) | 33(30.3) | 14(37.8) | 0.71 (0.33;1.56) | 0.395 |
 Cardiovascular (%) | 42(38.5) | 8(21.6) | 2.27 (0.95;5.44) | 0.061 |
 Hematological (%) | 87(79.8) | 24(64.9) | 2.14 (0.94;4.87) | 0.066 |
 Endocrine (%) | 30(27.5) | 11(29.7) | 0.9 (0.4;2.04) | 0.796 |